drugset / Trial / NCT07827599

A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants

NCT07827599 ↗

Phase 3 Not yet recruiting 325 enrolled Hoffmann-La Roche
RandomizedParallel-groupTriple-blindPrevention

Summary

The main purpose of the study is to evaluate the efficacy of a single dose of baloxavir marboxil compared with placebo in the PEP of influenza virus infection with respect to symptomatic, laboratory-confirmed influenza in participants who are household contacts (HHCs) of participants with influenza (index participants).

Timeline

Start
2026-09-22
Primary completion
2027-04-30
Completion
2027-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Baloxavir Marboxil Unknown — —

Indications